Triumph Capital Management’s Fresenius Medical Care FMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$67 Hold
3
– – ﹤0.01% 1883
2026
Q2
$68 Hold
3
– – ﹤0.01% 1836
2026
Q1
$68 Buy
+3
New +$69 ﹤0.01% 1810

Other funds holding FMS

Triumph Capital Management's FMS Position: Q3 2026 in Review

Triumph Capital Management held its Fresenius Medical Care (FMS) position steady in Q3 2026 at 3 shares worth $67. The position accounts for ﹤0.01% of the portfolio, ranked #1883.

Triumph Capital Management first reported a position in FMS in Q1 2026 and has held it in 3 quarters since. The position peaked at $68 in Q2 2026. 229 funds tracked by Wall St. Rank hold FMS as of Q3 2026.

  • Triumph Capital Management held 3 shares of Fresenius Medical Care worth $67 as of Q3 2026.
  • Triumph Capital Management left its Fresenius Medical Care share count unchanged in Q3 2026.
  • Fresenius Medical Care made up ﹤0.01% of Triumph Capital Management's portfolio in Q3 2026, its #1883 holding.
  • Triumph Capital Management first reported a position in Fresenius Medical Care in Q1 2026 and has held it in 3 quarters since.
  • Triumph Capital Management's Fresenius Medical Care position peaked at $68 in Q2 2026.
  • 229 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q3 2026.

Based on Triumph Capital Management's 13F filing for Q3 2026, filed 14 Oct 2026.